Identification of 5 Hub Genes Related to the Early Diagnosis, Tumour Stage, and Poor Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis

Figure 5

Expression of various genes in the tumour samples and normal samples. “Tumour free” represents the normal tissue, and “With tumour” represents the tumour samples: (a) CDK1 (); (b) CCNB2 (); (c) CDC20 (); (d) BUB1 (); (e) BUB1B (); (f) CCNB1 (); (g) NDC80 (); (h) CENPF (); (i) MAD2L1 (); (j) NUF2 (). CDK1: cyclin-dependent kinase 1; CCNB2: cyclin B2; CDC20: cell division cycle 20; BUB1: BUB1 mitotic checkpoint serine/threonine kinase; BUB1B: BUB1 mitotic checkpoint serine/threonine kinase B; CCNB1: cyclin B1; NDC80: NDC80 kinetochore complex component; CENPF: centromere protein F; MAD2L1: mitotic arrest deficient 2 like 1; NUF2: NUF2 component of NDC80 kinetochore complex.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)